As the **Scientific Critic and Teacher**, I have reviewed your submission on the computational landscape of epitope mapping.

### **Assessment Score: 95/100**
**Status: CERTIFIED**

---

### **Detailed Evaluation:**

#### **1. Biological Accuracy (Score: 94/100)**
You have accurately identified the dual role of glycans in epitope mapping: as targets themselves and as "shields" that hinder accessibility. Your distinction between **linear** and **conformational epitopes** is central to immunology and is correctly linked to structural stability. The integration of thermal stability ($T_m$) data—specifically citing the drop from 59°C to 56°C in the Grb7 SH2 domain—demonstrates an excellent understanding of how biophysical integrity dictates immunological visibility.

#### **2. Tool Awareness (Score: 98/100)**
Your technical proficiency is highly evident. You correctly identified:
*   **AlphaFold** as a high-resolution starting point but noted its limitations regarding dynamics and PTMs (post-translational modifications).
*   **GLYCAM06** as the gold-standard force field for carbohydrate simulations, which is often a "missing link" in standard protein-centric MD workflows.
*   **HADDOCK’s** specific utility in **Ambiguous Interaction Restraints (AIRs)**, which is the correct technical terminology for its information-driven docking approach.

#### **3. Reasoning and Synthesis (Score: 93/100)**
The workflow you proposed (**Scaffold $\rightarrow$ Dynamics $\rightarrow$ Docking**) is the industry standard for rational vaccine and therapeutic design. Your concept of **"4D Epitope Mapping"** (incorporating the temporal movement of glycan shields) shows a forward-thinking perspective on the field. You successfully bridged the gap between "wet lab" data (NMR, mutagenesis, $T_m$) and "dry lab" prediction.

---

### **Critique & Feedback:**

*   **Strength:** Your synthesis of the "glycan forest" concept with MD simulation is particularly strong. It addresses a major pitfall in structural biology where researchers often treat glycoproteins as static, naked proteins.
*   **Minor Improvement:** While you mentioned **HADDOCK** for docking, in the context of high-resolution epitope mapping, mentioning **solvent accessibility (RSA)** calculations or **SASA (Solvent Accessible Surface Area)** analysis within the GROMACS pipeline would further strengthen the argument for identifying "vulnerable patches." 
*   **Note on Citations:** You effectively utilized the provided data (Grb7 mutants). In a real-world manuscript, ensure the distinction between "predicted" binding free energy ($\Delta \Delta G$) and "measured" experimental affinity ($K_d$) is explicit, as computational alanine scanning can sometimes overestimate the magnitude of hotspot contributions.

**Final Remark:** This is a sophisticated, professional-grade summary. You have successfully demonstrated the ability to integrate diverse computational tools into a cohesive biological narrative. **Congratulations on your Certification.**